Sign in

CIK 0001621227

  • Non-accelerated filer
  • Smaller reporting company

Adaptimmune Therapeutics PLC

Sign in to watch
Ticker
ADAPY
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
United Kingdom
Entity type
Operating
Phone
+44 1235430000
Business address
60 JUBILEE AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom
Former names
Adaptimmune Ltd
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2024-07-01 Alleva Lawrence M Director Grant or award · Option to purchase Ordinary Shares +1,213,926 1,213,926
2023-07-03 Alleva Lawrence M Director Grant or award · Option to purchase Ordinary Shares +1,077,756 1,077,756
2022-07-01 Alleva Lawrence M Director Grant or award · Option to purchase Ordinary Shares +816,067 816,067
2021-07-01 Alleva Lawrence M Director Grant or award · Option to purchase Ordinary Shares +505,918 505,918
2021-06-01 Alleva Lawrence M Director Purchase +12,600 $0.79 $10K 12,600
2020-07-01 Alleva Lawrence M Director Grant or award · Option to purchase Ordinary Shares +197,678 197,678
2020-06-09 Alleva Lawrence M Director Purchase +12,900 $1.89 $24K 12,900
2019-07-02 Alleva Lawrence M Director Grant or award · Option to purchase Ordinary Shares +271,209 271,209
2018-12-17 Alleva Lawrence M Director Purchase +47,280 $0.84 $40K 47,280
2018-06-22 Alleva Lawrence M Director Grant or award · Option to purchase Ordinary Shares +124,000 124,000
2017-07-03 Alleva Lawrence M Director Grant or award · Option to purchase Ordinary Shares +243,724 243,724
2016-08-11 Alleva Lawrence M Director Grant or award · Option to purchase Ordinary Shares +196,678 196,678

Page 1 of 1 · 12 trades